INTRODUCTION
============

In bacterial cell division, cytokinesis is performed by a multi-protein complex called the divisome, which is composed of at least nine proteins (FtsA, FtsI, FtsK, FtsL, FtsN, FtsQ, FtsW, FtsZ, and ZipA) ([@b22-molce-39-11-814]). FtsZ, a tubulin homolog, has a significant role in initiating divisome assembly by forming an organized polymer called the FtsZ ring (Z-ring), which then recruits other division proteins ([@b28-molce-39-11-814]). The Z-ring can be mobilized by FtsA or ZipA to the membrane and is located midcell ([@b1-molce-39-11-814]). FtsA interacts with the C-terminal domain of FtsZ, which enhances initial assembly and stability of the Z-ring ([@b1-molce-39-11-814]; [@b20-molce-39-11-814]), while ZipA, a bitopic integral inner membrane protein, interacts with the C-terminal tail of FtsZ and anchors the complex to the membrane ([@b13-molce-39-11-814]; [@b21-molce-39-11-814]). After adhering the Z-ring to the membrane, other division proteins, FtsI, FtsK, FtsW, FtsQ, FtsL, and FtsB, form the premature divisome. Then, the divisome matures through the adhesion of several proteins (PBP1B, LpoB, MltA, and EnvC) and binds to peptidoglycans and the outer membrane ([@b9-molce-39-11-814]). The complete matured divisome is constricted by bending force and depolymerization of FtsZ filaments ([@b26-molce-39-11-814]).

FtsZ is highly conserved in most bacteria such as eubacteria and archaea, and is also seen in chloroplasts and some primitive mitochondria ([@b11-molce-39-11-814]). The N-terminal domain of FtsZ, a guanosine triphosphate hydrolase (GTPase), is responsible for polymerization through the head-to-tail interaction between the guanosine triphosphate (GTP) binding pocket and the C-terminal T7 loop ([@b3-molce-39-11-814]; [@b9-molce-39-11-814]). FtsZ polymerization is highly regulated by several proteins, which are classified as positive or negative regulators depending on their effects. Positive regulators of FtsZ are crucial for tethering FtsZ polymers to the membrane and encouraging the formation of stable lateral interactions to assemble a mature Z-ring ([@b15-molce-39-11-814]). Negative regulators of FtsZ have a critical role in positioning FtsZ at the prospective site of division and for sustaining Z-ring dynamics by regulating the process of FtsZ polymer assembly and disassembly ([@b15-molce-39-11-814]).

Zaps, which are FtsZ positive regulators, include ZapA, ZapB, ZapC, and ZapD and they are structurally characterized ([@b8-molce-39-11-814]; [@b19-molce-39-11-814]; [@b25-molce-39-11-814]; [@b29-molce-39-11-814]). ZapA is well known as a positive regulator of Z-ring formation, which can bind to FtsZ at the globular core directly ([@b12-molce-39-11-814]). ZapC also interacts with FtsZ at the globular core and increases Z-ring stability ([@b15-molce-39-11-814]). Recently, the crystal structure of ZapC from *E. coli* showed that ZapC is a monomer composed of two domains and it binds the FtsZ globular core rather than C-terminal tail ([@b30-molce-39-11-814]). ZapD deletion in cells resulted in no significant change in cell viability, however, decreased viability was observed in the polymerization-defective FtsZ84 (Ts) cells, suggesting that ZapD is a positive regulator of FtsZ protofilament formation ([@b7-molce-39-11-814]; [@b15-molce-39-11-814]). ZapD was shown to directly bind the C-terminal tail region of FtsZ as a positive regulator ([@b7-molce-39-11-814]).

Despite extensive previous studies on the architecture of the Z-ring, the molecular mechanism of how FtsZ protofilaments are assembled to form a mature Z-ring by Zap proteins is still poorly understood. Towards such an understanding, we sought to characterize the structure and function of ZapD to elucidate how ZapD promotes the assembly of FtsZ protofilaments and acts as a positive regulator of Z-ring formation. Here, we report the crystal structures of two ZapD proteins from *S. typhimurium* and *E. coli*, which share 89% amino-acid sequence identity. Several conserved residues are clustered on the concave surface of the EcZapD dimer, which is the suggested FtsZ binding site. The opposite surface of the StZapD or EcZapD dimer is rich in conserved positively charged Arg residues. The structural and biochemical studies on ZapD from *S. typhimurium* and *E. coli* suggest that the two FtsZ binding sites of StZapD and Ec-ZapD dimers might be responsible for binding to two FtsZ protofilaments to hold them together.

MATERIALS AND METHODS
=====================

Cloning and protein preparation
-------------------------------

The *S. typhimurium* ZapD~1-247~ gene was amplified with polymerase chain reaction (PCR) from its genomic DNA. The forward and reverse oligonucleotide primers were 5′-C G CTA TAT **GGA TCC** C [GAA AAC CTG TAT TTT CAG GGC]{.ul} ATG CAC ACC CAG GTC CTA TTT G-3′ and 5′-G CTA ATT **CTC GAG** TTA GCA ACA GGC CAG TTC AAA AT-3′, respectively. The bases in bold represent the *Bam*HI and *Xho*I restriction enzyme cleavage sites, and underlined sequences indicate the additional Tobacco Etch Virus (TEV) protease recognition site. The amplified DNA was digested using *Bam*HI and *Xho*I, and then introduced into *Bam*HI/*Xho*I digested pRSFDuet-1 (Novagen) expression vector.

Methods for expression and purification of EcZapD protein (residues 2-247) are similar to previously published methods ([@b33-molce-39-11-814]). The EcZapD WT and mutants (residues 1-247, E8A, E22R, H140R, or R176A) were cloned into a pHis-parallel2 vector ([@b31-molce-39-11-814]). Constructs of EcZapD WT and EcZapD mutants with an N-terminal His-tag followed by TEV protease cleavage site (ENLYFQG) were expressed in *E. coli* strain BL21(DE3)--pLysS cells as a host, while StZapD with an N-terminal His-tag followed by TEV protease cleavage site was expressed in *E. coli* strain BL21(DE3) cells as a host. The cells were treated with 0.5 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) to induce protein expression at 20°C for 20 h. Cells were lysed by passage through a Microfluidizer (Microfluidics, USA) in 20 mM Tris-HCl pH 7.9, 500 mM NaCl, 5 mM imidazole, and 1 mM phenylmethylsulfonyl fluoride (PMSF). The protein was purified using a Ni-sepharose affinity column, and was further purified by size exclusion chromatography (HiLoad 16/600 Superdex 75 prep grade, GE Healthcare) and stored in small aliquots at −80°C.

EcFtsZ peptides (GST-FtsZ~367-383~, GST-FtsZ~367-383~ K380D, GST-FtsZ~372-383~, and GST-FtsZ~367-379~) were fused to an N-terminal GST tag followed by a TEV protease cleavage site. The GST-FtsZ~367-383~ construct was amplified by PCR. The forward and reverse primers used to amplify the GST-FtsZ~367-383~ construct were 5′-G CTA TAT **GGA TCC** AAA GAG CCG GAT TAT CTG GAT-3′ and 5′-G CTA ATT **CTC GAG** TTA ATC AGC TTG CTT ACG-3′, respectively. The bases in bold represent *Bam*HI and *Xho*I restriction enzyme cleavage sites. Amplified DNA was digested with *Bam*HI and *Xho*I and was then inserted into the *Bam*HI/*Xho*I-digested expression vector pGST-parallel2 ([@b31-molce-39-11-814]). The plasmids were transformed into *E. coli* BL21(DE3) cells (Invitrogen), and cells harboring the plasmids were grown at 37°C until the optical density (at 600 nm) reached 0.7--1.0 in Luria Bertani (LB) broth containing 100 μg/ml ampicillin. Then, 0.5 mM IPTG was used to induce protein expression in the cells, after which the cells were incubated for 3 h at 37°C. Cells were harvested by centrifugation at 5,000 rpm at 4°C for 20 min, and the pellet was resuspended in ice-cold lysis buffer A (20 mM Tris-HCl pH 8.0 and 200 mM NaCl) containing 1 mM PMSF. The cells were lysed using microfluidizer (Microfluidics, USA), and the lysed cells were centrifuged at 12,000 rpm (Vision V506CA rotor) at 4°C for 30 min to separate the supernatant and cell debris. The supernatant was applied to a glutathione-Sepharose column (GE Healthcare) pre-equilibrated with lysis buffer. Initially, the column was washed extensively with lysis buffer A, after which the protein was eluted with elution buffer (150 mM Tris-HCl pH 8.0 and 15 mM reduced glutathione). Further purification was performed by gel filtration on a HiLoad 16/600 Superdex 75 prep-grade column (GE Healthcare), which was equilibrated with buffer A.

Crystallization, structure determination, and refinement
--------------------------------------------------------

The crystallization method and the data processing parameters for EcZapD (residues 2-247) has been published elsewhere ([@b33-molce-39-11-814]). The structure of EcZapD was solved by the molecular replacement method using the DUF1342 model from *Vibrio parahaemolyticus* (unknown function, PDB ID: 2OEZ) as the probe. Crystals of the StZapD (residues 1-247) were grown at 293 K using the sitting drop method by mixing 1 μl of the StZapD solution at 12 mg/ml in 20 mM Tris-HCl (pH 8.0), 200 mM NaCl, and 1 mM dithiothreitol (DTT) with 1 μl of the reservoir solution consisting of 1.1M sodium malonate, 100 mM HEPES (pH 7.5), and 0.5%(v/v) Jeffamin ED-2001 (pH7.0). Data sets were collected at 100 K in 1° oscillations at the BL38B1 beamline of SPring-8. Crystals of StZapD diffracted to a resolution of 2.6 Å ([Table 1](#t1-molce-39-11-814){ref-type="table"}), and the diffraction data were processed and scaled using the *HKL2000* software package ([@b27-molce-39-11-814]). The structure was solved using the molecular replacement method using the DUF1342 model as a probe. The crystal belonged to space group P6~3~22 with unit cell parameters of a = 84.2 Å, b = 84.2 Å, and c = 150.4 Å. A cross-rotational search followed by a translational search was performed using the *PHASER* program ([@b23-molce-39-11-814]). Subsequent manual model building was performed using the *COOT* program ([@b10-molce-39-11-814]) and restrained refinement was carried out using the *REFMAC5* program ([@b24-molce-39-11-814]). Several rounds of model building, simulated annealing, positional refinement, and individual B-factor refinement were performed using the *COOT* and *REFMAC5* programs. As the test data for the calculation of *R*~free~, 5% of the data were randomly set aside ([@b2-molce-39-11-814]). The coordinates and structure factors for StZapD and EcZapD have been deposited in the Protein Data Bank under accession numbers 5GNP and 5IMJ, respectively.

Size exclusion chromatography with multi-angle light scattering (SEC-MALS)
--------------------------------------------------------------------------

SEC-MALS experiments for EcZapD and StZapD were performed using a FPLC system (GE Healthcare) connected to a Wyatt MiniDAWN TREOS MALS instrument and a Wyatt Optilab rEX differential refractometer. A Superdex 200 10/300 GL (GE Healthcare) gel-filtration column pre-equilibrated with buffer A was normalized using ovalbumin protein. Proteins were injected (1 mg) at a flow rate of 0.4 ml/min. Data were analyzed using the Zimm model for static light-scattering data fitting and graphed using EASI graph with a UV peak in the ASTRA V software (Wyatt).

Bio-layer interferometry (BLI) measurement
------------------------------------------

BLI measurements were carried out to demonstrate binding between EcZapD (WT or mutants) and EcFtsZ (GST-FtsZ~367-383~, GST-FtsZ~367-383~ K380D, GST-FtsZ~372-383~, or GST-FtsZ~367-379~) by using a BLItz system (ForteBio, Menlo Park, CA). EcFtsZ proteins (GST-FtsZ~367-383~, GST-FtsZ~367-383~ K380D, GST-FtsZ~372-383~, or GST-FtsZ~367-379~) were immobilized on an AR2G biosensor chip surface using amine coupling in 20 mM sodium acetate (pH 4.0). The surface was activated by a 5-min immersion of N-hydroxysuccinimide (NHS)/ethyl(dimethyl-aminopropyl) carbodiimide (EDC). Subsequently, the AR2G biosensor chip was blocked by a 5-min immersion of 1 M ethanolamine. The surface was equilibrated with buffer A. To determine whether interactions occur between EcZapD (WT, E22R, and H140R) and EcFtsZ (GST-FtsZ~367-383~, GST-FtsZ~367-383~ K380D, GST-FtsZ~372-383~, or GST-FtsZ~367-379~), the prepared AR2G biosensor chip was dipped in 35 μM protein solution in running buffer. Associations between EcZapD (WT, E22R, and H140R) and EcFtsZ (GST-FtsZ~367-383~, GST-FtsZ~367-383~ K380D, GST-FtsZ~372-383~, or GST-FtsZ~367-379~) were measured for 150 s, and dissociations were measured for 150 s.

RESULTS AND DISCUSSION
======================

Structure determination of EcZapD and StZapD
--------------------------------------------

We have determined the crystal structures of EcZapD (residues 2-247) and StZapD (1-247) by the molecular replacement method using the DUF1342 model from *V. parahaemolyticus* (unknown function, PDB ID: 2OEZ) as the probe. To facilitate crystallization, the N-terminus of EcZapD (residue number 1) was truncated. Two monomers of EcZapD belong to the space group *P*6~4~, with unit cell parameters of a = b = 109.5 Å, and c = 106.7 Å. The model of EcZapD has been refined to crystallographic *R*~work~ and *R*~free~ values of 22.7% and 28.3% for the 35.4-3.1 Å data ([Table 1](#t1-molce-39-11-814){ref-type="table"}). The refined EcZapD model has one dimer in an asymmetric unit with 492 residues, 5 sulfate ions, and 41 water molecules, respectively. Ramachandran plot analysis for the model showed that 86.3% and 10.2% of the non-glycine residues were in the most favored and allowed regions, and 3.5% of them were in disallowed regions ([Table 1](#t1-molce-39-11-814){ref-type="table"}). The outlier residues are located in regions of fairly poor density.

One monomers of StZapD belong to the space group *P*6~3~22, with unit cell parameters of a = b = 84.2 Å, and c = 150.0 Å. The model of StZapD has been refined to crystallographic *R*~work~ and *R*~free~ values of 24.8% and 27.7% for the 50--2.8 Å data ([Table 1](#t1-molce-39-11-814){ref-type="table"}). The refined StZapD model has one monomer in an asymmetric unit with 245 residues, 1 malonate ion, and 36 water molecules. Ramachandran plot analysis for the model showed that 95.9% and 3.7% of the non-glycine residues were in the most favored and allowed regions, and 0.4% of them were in disallowed regions ([Table 1](#t1-molce-39-11-814){ref-type="table"}). The outlier residues are located in regions of fairly poor density.

Overall structure of StZapD and its oligomeric state in solution
----------------------------------------------------------------

The StZapD monomer is composed of two domains; the N-terminal α-helices domain (NTD) and the C-terminal β-sheet domain (CTD) ([Figs. 1](#f1-molce-39-11-814){ref-type="fig"} and [2](#f2-molce-39-11-814){ref-type="fig"}). The NTD consists of eight α-helices, while the CTD consists of seven β strands ([Figs. 1](#f1-molce-39-11-814){ref-type="fig"} and [2](#f2-molce-39-11-814){ref-type="fig"}). The CTD is composed of two antiparallel β-sheets (β1-β4-β7-β2 and β5-β6-β3, respectively) facing each other ([Fig. 1A](#f1-molce-39-11-814){ref-type="fig"}). Interestingly, the N-terminal β1 is part of the C-terminal β-sheet. The asymmetric crystallization unit contains one monomer, and its dimeric assembly with approximate dimensions of 90 Å × 60 Å × 30 Å presents twofold symmetry ([Fig. 1B](#f1-molce-39-11-814){ref-type="fig"}). To unveil overall structural similarities with other known structures from PDB, a search using the DALI program was performed ([@b14-molce-39-11-814]). It showed several structurally similar proteins including (i) cell division protein ZapD from *E. coli* (5DKO, Z-score 30) ([@b29-molce-39-11-814]), (ii) the DUF1342 protein (unknown function) from *V. parahaemolyticus* (2OEZ, Z-score 27), and (iii) Integron cassette protein from *V. paracholerae* (3JRT, Z-score 8.2) ([@b34-molce-39-11-814]). When we compared our StZapD refined structure with the high Z-score structures (PDB codes 5DKO, 2OEZ, and 3JRT), the r.m.s. deviations were 0.9 Å (240 Cα), 2.0 Å (240 Cα), and 5.6 Å (120 Cα) for Cα atom pairs, respectively.

The solvent-accessible surface area buried at the interface between the two monomers in the dimeric unit of StZapD was calculated by PISA ([@b17-molce-39-11-814]), to be \~1871 Å^2^ (13% of the monomer surface area), suggesting that StZapD may exist in solution as the dimer that is present in the crystal. To further analyze the oligomeric states of StZapD and EcZapD in solution, we measured the molecular weight of StZapD using SEC-MALS. The molecular masses of StZapD and EcZapD were 55.5 and 54.6 kDa, close to the theoretical molecular mass of dimeric StZapD (56.9 kDa) and EcZapD (56.8 kDa) in solution, respectively ([Fig. 1C](#f1-molce-39-11-814){ref-type="fig"}), indicating that the functional oligomeric state of StZapD and EcZapD in solution is dimer. It is interesting to note that other structurally characterized Zap proteins (ZapA, ZapB, and ZapC) also exist as dimer in solution, even though ZapA exists in a dimer-tetramer equilibrium in concentration-dependent manner ([@b8-molce-39-11-814]; [@b19-molce-39-11-814]; [@b25-molce-39-11-814]).

The binding activity of EcZapD to the C-terminal peptide of FtsZ
----------------------------------------------------------------

The C-terminal peptide of FtsZ consists of highly conserved residues and interacts with diverse FtsZ-interacting proteins, including FtsZ, ZipA, SepF, EzrA, and ZapD ([@b15-molce-39-11-814]; [@b32-molce-39-11-814]). A previous report showed that the C-terminal peptide of FtsZ could be divided into two parts---the C-terminal constant region (CTC, ^367^KEPDYLDIPAFLR^379^ in EcZapD) consisting of conserved residues, and a C-terminal variable region (CTV, ^380^KQAD^383^ in EcZapD) consisting of sequences diverse in length and composition ([@b15-molce-39-11-814]). To confirm the predicted function of EcZapD as an FtsZ binding protein, we attempted to measure the catalytic activity of FtsZ binding by bio-layer interferometry (BLI) experiments. BLI assays were performed by attaching C-terminal FtsZ peptides from *E. coli* (residues 367-383, 372-383, or 367-379) with GST tags (GST-FtsZ~367-383~, GST-FtsZ~372-383~, or GST-FtsZ~367-379~) on an AR2G biosensor chip to check whether EcZapD (WT or mutants) contains peptide binding activity ([Fig. 3](#f3-molce-39-11-814){ref-type="fig"}). To ensure that the EcZapD proteins did not bind to the GST protein, but to the C-terminal FtsZ peptide specifically, a control chip containing GST only without the C-terminal FtsZ peptide was utilized. Indeed, EcZapD bound tightly to the GST-FtsZ~367-383~ but not to the GST protein only ([Figs. 3A and 3B](#f3-molce-39-11-814){ref-type="fig"}), indicating that the interaction between EcZapD and the C-terminal FtsZ peptide is specific. Thus, the FtsZ binding activity suggests that EcZapD is a direct modulator of FtsZ protofilaments. To check whether the N-terminal part of the CTC region is essential for EcZapD binding, we attempted to remove the five N-terminal residues (residues 367-371) of the CTC region for an EcZapD binding study. The binding affinities of EcZapD with EcFtsZ proteins (residues 367-383 and 372-383) were 4.4 ± 0.5 and 10 ± 0.9 μM, respectively, suggesting that residues 372-383 of FtsZ are sufficient for its binding to EcZapD ([Fig. 3B](#f3-molce-39-11-814){ref-type="fig"}). In addition, to check whether the CTV region is essential for EcZapD binding, we removed the CTV part (residues 380-383) and measured its binding affinity with EcZapD. The binding affinity was significantly lower (K~d~ \> 2 mM) than those of other EcFtsZ constructs (residues 367-383 or 372-383), suggesting that the CTV region of FtsZ, ^380^KQAD^383^, is essential for binding to EcZapD ([Fig. 3B](#f3-molce-39-11-814){ref-type="fig"}). In recent study, the importance of K380 of FtsZ in the CTV region was reported ([@b16-molce-39-11-814]). Thus, we performed another BLItz assay between EcFtsZ (367-383) K380D mutant and EcZapD and measured its binding affinity (K~d~ = 4.7 ± 0.5 μM) ([Supplementary Fig. S1A](#s1-molce-39-11-814){ref-type="supplementary-material"}). It showed similar binding affinity with EcFtsZ WT (367-383) ([Fig. 3B](#f3-molce-39-11-814){ref-type="fig"}), suggesting that the mutation of K380D in EcFtsZ (367-383) is not enough to abolish the interaction with EcZapD.

Putative FtsZ binding sites on EcZapD and modeled structure of EcZapD~2-247~-FtsZ~367-383~ complex
--------------------------------------------------------------------------------------------------

When the molecular surface of EcZapD was drawn, two deep clefts between two monomers were found on the concave surface of EcZapD ([Fig. 3](#f3-molce-39-11-814){ref-type="fig"}). The calculated volumes of each cavity using the CASTp server ([@b6-molce-39-11-814]) were 166 Å^3^ and 98 Å^3^, respectively. Along this cleft, several conserved residues are clustered, including Glu8, Glu22, His140, and Arg176 ([Fig. 3A](#f3-molce-39-11-814){ref-type="fig"}). This cleft appeared to be the site of FtsZ binding, thus we tried to solve the crystal structure of EcZapD~2-247~-FtsZ~367-383~ complex. However, we could not produce the crystal of Ec-ZapD~2-247~-FtsZ~367-383~ complex despite of various screening trials. Thus, using the FlexPepDock server ([@b18-molce-39-11-814]), we have modeled the complex of EcZapD~2-247~ with FtsZ~367-383~ to identify the FtsZ~367-383~ binding site on EcZapD~2-247~ ([Fig. 3A](#f3-molce-39-11-814){ref-type="fig"}). As expected, the deep clefts between the two monomers, which were suggested to be the FtsZ binding site, were indeed responsible for FtsZ~367-383~ binding. Along with the FtsZ~367-383~ binding site, there were two strictly conserved residues (Glu22 and His140). Therefore, to validate this model, EcZapD mutants (E22R and H140R) were tested to determine if the mutations weaken the FtsZ binding affinity for EcZapD. Indeed, mutations of Glu22 and His140 to Arg led to slightly lower binding (K~d~ = 68 ± 2.2 μM and 16 ± 1 μM, respectively) than that with WT Ec-ZapD (4.4 ± 0.5 μM), suggesting the contributions of the two conserved residues to the binding between EcZapD and EcFtsZ ([Fig. 3B](#f3-molce-39-11-814){ref-type="fig"}). We could not measure the binding affinities with the E8A and R176A mutants of FtsZ~367-383~, because these proteins were expressed in insoluble forms ([Supplementary Fig. S1B](#s1-molce-39-11-814){ref-type="supplementary-material"}). Based on these results, we speculated that both Glu22 and His140 contribute to the binding of EcZapD to FtsZ directly or indirectly. Although much remains to be learned about the structural architecture of FtsZ-ZapD complex and the mechanism of FtsZ protofilaments stabilization by EcZapD, the results and model presented here provide one foothold for furthering such an understanding.
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![Overall structure of StZapD and oligomeric state in solution. (A) Stereo ribbon diagram of monomer structure of StZapD. The NTD (N-terminal domain) and CTD (C-terminal domain) are shown in light blue and gold, respectively. Loops are drawn in gray. Right panel indicates domain architectures of Ec-ZapD and EcFtsZ ([@b16-molce-39-11-814]). EcFtsZ constructs used in biochemical analysis are shown in bold line. C-terminal constant region and C-terminal variable region are denoted as CTC and CTV, respectively. (B) Ribbon diagram of StZapD dimer structure. (C) The molecular weights of EcZapD and StZapD in solution were analyzed by SECMALS. The thick lines represent the measured molecular weight.](molce-39-11-814f1){#f1-molce-39-11-814}

![Sequence alignments of StZapD with other ZapD proteins. Multi-alignment of *E. coli* (UniProtKB/Swiss-Prot accession number J7QWY2) against ZapD from *S. typhimurium* ZapD (Uni-ProtKB/Swiss-Prot accession number P67693), *Salmonella choleraesuis* (Uni-ProtKB/Swiss-Prot accession number Q57TB7), *Shigella sonnei* (Uni-ProtKB/Swiss-Prot accession number Q3Z5Q7), *Shigella flexneri* (Uni-ProtKB/Swiss-Prot accession number Q83MF4), *Yersinia pestis* (UniProtKB/Swiss-Prot accession number Q8ZBH9), *Vibrio parahaemolyticus* (UniProtKB/Swiss-Prot accession number Q87LT3), *Vibrio vulnificus* (UniProtKB/Swiss-Prot accession number P67695), *Vibrio cholerae sero-type O1* (UniProtKB/Swiss-Prot accession number P67694), and *Vibrio fischeri* (UniProtKB/Swiss-Prot accession number Q5E2R1). Secondary structure elements were assigned by PyMOL (The PyMOL Molecular Graphics System, <http://www.pymol.org>) and every twentieth residue is marked by a black dot. Strictly (100%) and semi-conserved residues (80% and 60%) are highlighted in green, cyan, and yellow, respectively. Arrows and cylinders above the sequences denote α-helices and β-strands, respectively. Blue triangles indicate the mutation sites for EcZapD-EcFtsZ binding study.](molce-39-11-814f2){#f2-molce-39-11-814}

![Modeled structure of EcZapD in complex with FtsZ peptides (residues 367-383). (A) Modeled structure of EcZapD-FtsZ complex. Sequence conservation was mapped onto the surface of the EcZapD dimer. The conserved residues are shown in green (100%), cyan (greater than 80%), and yellow (greater than 60%). CTC and CTV regions are shown in light pink and magenta colors, respectively ([@b16-molce-39-11-814]). (B) Left two panels indicate representative BLI binding sensorgrams of GST-FtsZ~367-383~ with EcZapD mutants (E22R and H140R). Right three panels indicate representative BLI binding sensorgrams of EcZapD WT with GST-FtsZ~367-383~, GST-FtsZ~372-383~, and GST-FtsZ~367-379~, respectively. The experiments were repeated three times. Each concentration of analytes is shown in a different color.](molce-39-11-814f3){#f3-molce-39-11-814}

![Surface representation of the sequence conservation and electrostatic potential of StZapD. (A) Sequence conservation mapped onto the surface of the StZapD dimer. The conserved residues are green (100%), cyan (greater than 80%), and yellow (greater than 60%). The predicted FtsZ binding sites are indicated as red dotted circles. (B) Surface representation and electrostatic potential rotated 180° around the indicated axis in comparison to the upper figure are shown below. The positions of conserved positively charged residues are indicated.](molce-39-11-814f4){#f4-molce-39-11-814}

###### 

Statistics for data collection and refinement

  --------------------------------------------------------------------------------------------------------------------------------------------------
  Data set                                                               StZapD                                                        EcZapD
  ---------------------------------------------------------------------- ------------------------------------------------------------- -------------
  ***A. crystal parameters***                                                                                                          

  X-ray source                                                           BL38B1                                                        

  X-ray wavelength (Å)                                                   1.0000                                                        

  Space group                                                            P6~3~22                                                       

  Unit cell parameters (Å)                                               a = 84.2\                                                     
                                                                         b = 84.2\                                                     
                                                                         c = 150.0                                                     

  Resolution range (Å)                                                   50--2.8                                                       

  Total/unique reflections                                               107,772/8,289                                                 

  Completeness (%)                                                       99.7 (100.0)[a](#tfn1-molce-39-11-814){ref-type="table-fn"}   

  Average *I*/σ (*I*)                                                    48.6 (5.9)[a](#tfn1-molce-39-11-814){ref-type="table-fn"}     

  *R*~rim~ [b](#tfn2-molce-39-11-814){ref-type="table-fn"} (%)           11.3(62.4)[a](#tfn1-molce-39-11-814){ref-type="table-fn"}     

  *R*~pim~ [c](#tfn3-molce-39-11-814){ref-type="table-fn"}(%)            3.2(16.3)[a](#tfn1-molce-39-11-814){ref-type="table-fn"}      

  *CC~1/2~* [d](#tfn4-molce-39-11-814){ref-type="table-fn"} (%)          99.7(93.7)[a](#tfn1-molce-39-11-814){ref-type="table-fn"}     

  ***B. Model refinement statistics***                                                                                                 

  Resolution range (Å)                                                   50--2.8                                                       35.4-3.1

  *R~work/~R~free~* [e](#tfn5-molce-39-11-814){ref-type="table-fn"}(%)   24.8/27.7                                                     22.7/28.3

  Number/average *B*-factor (Å^2^)                                                                                                     

   Protein nonhydrogen atoms                                             1,983/83.0                                                    

   Water oxygen atoms                                                    36/72.7                                                       3,968/95.28

   Malonate                                                              1/100                                                         41/83.07

  R.m.s. deviations from ideal                                                                                                         

   Bond lengths (Å)                                                      0.005                                                         0.007

   Bond angles (°)                                                       0.927                                                         1.208

  Protein-geometry analysis                                                                                                            

   Ramachandran favored (%)                                              95.9                                                          86.3

   Ramachandran allowed (%)                                              3.7                                                           10.2

   Ramachandran outliers (%)                                             0.4                                                           3.5
  --------------------------------------------------------------------------------------------------------------------------------------------------

Values in parentheses refer to the highest resolution shell (2.85--2.80 Å).

R~rim~ = ∑~hkl~{*N*(*hkl*)/\[*N*(*hkl* )-- 1\>^1/2^ ∑~i~ \| *I*~i~(*hkl*) --\<*I*(*hkl*)\> \|/∑^hkl^∑~i~ *I*~i~(*hkl*). The redundancy-independent merging R factor gives the precision of individual intensity ([@b4-molce-39-11-814]).

R~pim~ = ∑~hkl~{1/\[*N*(*hkl* ) --1\>^1/2^ ∑~i~ \| *I*~i~(*hkl*) --\<*I*(*hkl*)\> \|/∑^hkl^∑~i~ *I*~i~(*hkl*). The precision indicating merging R factor describes the precision of the averaged intensity ([@b35-molce-39-11-814]).

CC^1/2^ is the correlation coefficient of the mean intensities between two random half-sets of data ([@b5-molce-39-11-814]).

*R* = ∑~hkl~ \| \|*F*~obs~\| -- \|*F*~calc~\| \|/∑~hkl~ \|*F*~obs~\|, where *R*~free~ was calculated for a randomly chosen 5% of reflections, which were not used for structure refinement and *R*~work~ was calculated for the remaining.

The data processing parameters for EcZapD have been described elsewhere with the reference ([@b33-molce-39-11-814])
